Save time and get answers to complex questions with AI chat
Is guselkumab off patent in u s?When did risperdal constas patent expire published article?Atorvastatin side effects heart palpitations?How many years does kadcyla's market exclusivity last?Dabrafenib mesylate when the patent is expiring in india?
See the DrugPatentWatch profile for pembrolizumab
Pembrolizumab is an antibody that targets the programmed death-1 (PD-1) receptor on immune cells. The ligand for PD-1 is PD-L1 (also called B7-H1). Sources: 1. DrugPatentWatch.com – Pembrolizumab (Keytruda) drug information
Other Questions About Pembrolizumab :